`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS
`USA, INC., and AKORN INC.1
`Petitioners
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.
`Patent Owners
`___________________
`
`Case IPR2016-01127 (8,685,930 B2)
`Case IPR2016-01128 (8,629,111 B2)
`Case IPR2016-01129 (8,642,556 B2)
`Case IPR2016-01130 (8,633,162 B2)
`Case IPR2016-01131 (8,648,048 B2)
`Case IPR2016-01132 (9,248,191 B2)
` ___________________
`
`
`PETITIONER TEVA PHARMACEUTICALS USA, INC.’S
`UPDATED MANDATORY NOTICES PURSUANT
`TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-
`00596, IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601,
`have respectively been joined with the captioned proceedings. The word-for-word
`identical paper is filed in each proceeding identified in the caption pursuant to the
`Board’s Scheduling Order (Paper 10).
`
`
`
`
`
`Petitioner Teva Pharmaceuticals USA, Inc. (“Teva”) hereby files these
`
`Updated Mandatory Notices Pursuant to 37 C.F.R. § 42.8(a)(3) to update the
`
`listing of counsel and service information.
`
`I. LEAD AND BACK-UP COUNSEL
`Teva hereby adds Ralph Wilson Powers III (Reg. No. 63,504) as back-up
`
`counsel:
`
`Ralph Wilson Powers III, Reg. No. 63,504
`tpowers-PTAB@sternekessler.com
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3932
`Tel.: 202-772-8876
`
`Fax: 202-371-2540.
`All previously-listed counsel for Teva remain the same.
`II. SERVICE INFORMATION
`Teva consents to electronic service by email at the email addresses
`
`
`
`gspeier@carlsoncaspers.com, mschuman@carlsoncaspers.com,
`
`IPRCyclosporine@carlsoncaspers.com, tpowers-PTAB@sternekessler.com, and
`
`PTAB@sternekessler.com.
`
`
`
`
`
`
`
`- 1 -
`
`
`
`
`
`Respectfully submitted,
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
` /
`
` R. Wilson Powers III/
`
`
`Ralph Wilson Powers III, Reg. No. 63,504
`Attorney for Petitioner Teva Pharmaceuticals USA,
`Inc.
`
`- 2 -
`
`
`
`Dated: December 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing PETITIONER TEVA
`
`PHARMACEUTICALS USA, INC.’S UPDATED MANDATORY NOTICES
`
`PURSUANT TO 37 C.F.R. § 42.8(a)(3) and Teva Pharmaceuticals USA, Inc.’s
`
`Updated Power of Attorney were served electronically via e-mail on December 26,
`
`2018, in their entireties on the following counsel of record for Patent Owners:
`
`Dorothy P. Whelan; Michael Kane; Susan
`Morrison Colletti; Robert M. Oakes;
`Jonathan Singer
`FISH & RICHARDSON P.C.
`IPR13351-0008IP1@fr.com
`IPR13351-0008IP2@fr.com
`IPR13351-0008IP3@fr.com
`IPR13351-0008IP4@fr.com
`IPR13351-0008IP5@fr.com
`IPR13351-0008IP6@fr.com
`PTABInbound@fr.com
`
`Alfonso Chan; Joseph DePumpo;
`Michael W. Shore;
`Christopher L. Evans
`SHORE CHAN DEPUMPO LLP
`achan@shorechan.com
`jdepumpo@shorechan.com
`mshore@shorechan.com
`cevans@shorechan.com
`
`Marsha K. Schmidt
`marsha@mkschmidtlaw.com
`
`
`And on the counsel for Petitioners as follows:
`
`Steven W. Parmelee; Michael T. Rosato;
`Jad A. Mills; Wendy L. Devine;
`Douglas H. Carsten
`WILSON SONSINI GOODRICH & ROSATI
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`wdevine@wsgr.com
`dcarsten@wsgr.com
`Attorneys for Mylan Pharmaceuticals Inc.
`
`
`
`
`Michael Dzwonczyk; Azadeh Kokabi;
`Travis Ribar
`SUGHRUE MION, PLLC
`mdzwonczyk@sughrue.com
`akokabi@sughrue.com
`tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`
`
`
`
`
`
`Gary J. Speier; Mark D. Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`gspeier@carlsoncaspers.com
`mschuman@carlsoncaspers.com
`IPRCyclosporine@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals
`USA, Inc.
`
`
`
`
`
`Dated: December 26, 2018
`
`
`
`
`
`
`
`
`Respectfully submitted,
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
` /
`
` R. Wilson Powers III/
`
`
`Ralph Wilson Powers III, Reg. No. 63,504
`Attorney for Petitioner Teva Pharmaceuticals USA,
`Inc.
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
